Russell Investments Group’s Indivior Pharmaceuticals INDV Stock Holding History

Russell Investments Group’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Sell	64,668 -3,612	-5%	-$131K	﹤0.01%	1923
2026 Q1	$2.06M	Sell	68,280 -277,875	-80%	-$9.18M	﹤0.01%	1865
2025 Q4	$12.4M	Sell	346,155 -56,740	-14%	-$1.73M	0.01%	805
2025 Q3	$9.71M	Buy	+402,895	New	+$8.43M	0.01%	918
2024 Q3	–	Sell	-2,210	Closed	-$34.6K	–	3741
2024 Q2	$34.6K	Hold	2,210	–	–	﹤0.01%	2841
2024 Q1	$47.3K	Hold	2,210	–	–	﹤0.01%	2676
2023 Q4	$33.4K	Sell	2,210 -342	-13%	-$6.07K	﹤0.01%	2683
2023 Q3	$55.4K	Buy	+2,552	New	+$58.2K	﹤0.01%	2737

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Russell Investments Group's INDV Position: Q2 2026 in Review

Russell Investments Group reduced its Indivior Pharmaceuticals (INDV) stake by 5.3% in Q2 2026, selling an estimated $131K and leaving 64,668 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Russell Investments Group first reported a position in INDV in Q3 2023 and has held it in 8 quarters since. The position peaked at $12.4M in Q4 2025. 140 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Russell Investments Group held 64,668 shares of Indivior Pharmaceuticals worth $2.65M as of Q2 2026.
Russell Investments Group sold 3,612 Indivior Pharmaceuticals shares in Q2 2026, an estimated $131K.
Indivior Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1923 holding.
Russell Investments Group first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
Russell Investments Group's Indivior Pharmaceuticals position peaked at $12.4M in Q4 2025.
140 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.